THE Therapeutic Goods Administration (TGA) has provided an update on its Australian clinical trial handbook, giving sponsors guidance on legislative, regulatory and good clinical practice (GCP) requirements when conducting clinical trials in Australia using 'unapproved' therapeutic goods.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 09 Mar 18
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Mar 18
